Ubs Group Ag Biogen Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Biogen Inc. stock. As of the latest transaction made, Ubs Group Ag holds 452,511 shares of BIIB stock, worth $78.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

452,511

Previous 151,600 198.49%

Holding current value

$78.6 Million

Previous $32.7 Million 220.91%

% of portfolio

0.03%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $4.44 Million - $5.52 Million	-23,315 Reduced 4.9%	452,511 $105 Million
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $29.1 Million - $36.8 Million	137,472 Added 40.63%	475,826 $103 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $18.1 Million - $21.8 Million	-81,444 Reduced 19.4%	338,354 $87.6 Million
Q3 2023 Nov 09, 2023	BUY	$253.3 - $285.89 $6.86 Million - $7.74 Million	27,066 Added 6.89%	419,798 $108 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $26.6 Million - $30.7 Million	96,648 Added 32.64%	392,732 $112 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $464,117 - $528,843	1,809 Added 0.61%	296,084 $82.3 Million
Q4 2022 Feb 08, 2023	BUY	$252.44 - $306.72 $37.2 Million - $45.2 Million	147,458 Added 100.44%	294,275 $81.5 Million
Q3 2022 Nov 10, 2022	SELL	$194.69 - $268.46 $25.8 Million - $35.6 Million	-132,493 Reduced 47.44%	146,817 $39.2 Million
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $15.8 Million - $18.8 Million	-84,208 Reduced 23.16%	279,310 $57 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $272,440 - $343,260	1,406 Added 0.39%	363,518 $76.6 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $10.8 Million - $13.9 Million	48,149 Added 15.34%	362,112 $86.9 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $21.2 Million - $27.6 Million	74,754 Added 31.25%	313,963 $88.8 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $10.4 Million - $16.6 Million	40,143 Added 20.17%	239,209 $82.8 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $8.31 Million - $9.73 Million	-34,199 Reduced 14.66%	199,066 $55.7 Million
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $23.1 Million - $34.8 Million	97,735 Added 72.11%	233,265 $57.1 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $47.8 Million - $55.2 Million	-180,410 Reduced 57.1%	135,530 $38.4 Million
Q2 2020 Jul 31, 2020	BUY	$258.66 - $342.55 $13.6 Million - $18 Million	52,443 Added 19.9%	315,940 $84.5 Million
Q1 2020 May 01, 2020	SELL	$268.85 - $341.04 $1.75 Million - $2.22 Million	-6,502 Reduced 2.41%	263,497 $83.4 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $26 Million - $36 Million	-118,267 Reduced 30.46%	269,999 $80.1 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $11.6 Million - $13 Million	53,176 Added 15.87%	388,266 $90.4 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $3.34 Million - $3.68 Million	-15,209 Reduced 4.34%	335,090 $78.4 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $32.3 Million - $50.5 Million	149,084 Added 74.09%	350,299 $82.8 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $47.5 Million - $60.2 Million	-170,596 Reduced 45.88%	201,215 $60.5 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $14.9 Million - $19.5 Million	50,901 Added 15.86%	371,811 $131 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $9.36 Million - $11.2 Million	-36,357 Reduced 10.18%	320,910 $93.1 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $21.9 Million - $31 Million	-84,362 Reduced 19.1%	357,267 $97.8 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $74.5 Million - $83.4 Million	242,120 Added 121.36%	441,629 $141 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $24.4 Million - $28.6 Million	-86,808 Reduced 30.32%	199,509 $62.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	111,258 Added 63.55%	286,317 $77.7 Million
Q1 2017 Nov 14, 2017	BUY	N/A	175,059	175,059 $47.9 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account